pentosidine has been researched along with Albuminuria in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correa-Giannella, MLC; Lira, ALA; Minanni, CA; Nakandakare, ER; Passarelli, M; Pinto, RS; Queiroz, MS; Ronsein, GE; Santana, MFM; Sawada, MIBAC; Silva, ARM | 1 |
| Hedayati, M; Hosseinpanah, F; Nafar, M; Noori, N; Tabibi, H | 1 |
| Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
| Azushima, K; Haku, S; Haruhara, K; Kanaoka, T; Kinguchi, S; Kobayashi, R; Ohki, K; Ohsawa, M; Tamura, K; Toya, Y; Umemura, S; Uneda, K; Wakui, H | 1 |
| Lin, CC; Yin, MC | 1 |
| Sugimoto, T; Yamaguchi, T; Yamamoto, M; Yamauchi, M | 1 |
| Erhard, P; Genuth, S; Kern, EF; Sun, W; Weiss, MF | 1 |
| Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
| Baynes, JW; Degenhardt, TP; Fu, MX; Neidlein, R; Reiff, K; Reiter, R; Strein, K; Thorpe, SR; Voss, E | 1 |
| Daimon, M; Eguchi, H; Hirata, A; Igarashi, M; Kato, T; Manaka, H; Ohnuma, H; Ono, Y; Saito, T; Yamaguchi, H | 1 |
3 trial(s) available for pentosidine and Albuminuria
| Article | Year |
|---|---|
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.
Topics: Adult; Aged; Albuminuria; Arginine; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyridoxine; Thioctic Acid | 2013 |
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
Topics: Aged; Albuminuria; Anticholesteremic Agents; Arginine; Cholesterol, HDL; Cholesterol, LDL; Diet; Dyslipidemias; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Oxidative Stress; Quinolines; Renal Insufficiency, Chronic; Triglycerides; Vascular Stiffness | 2015 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
7 other study(ies) available for pentosidine and Albuminuria
| Article | Year |
|---|---|
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis.
Topics: Aged; Aged, 80 and over; Albuminuria; Apolipoproteins A; Apolipoproteins D; Arginine; Case-Control Studies; Diabetic Nephropathies; Female; Gene Expression; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Interleukin-6; Kidney; Lipopolysaccharides; Lipoproteins, HDL; Lysine; Macrophages; Male; Middle Aged; Primary Cell Culture; Protein Carbamylation; Proteome; Renal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2020 |
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice.
Topics: Albuminuria; Animals; Arginine; Blood Glucose; Creatinine; Cysteine; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Kidney; Lysine; Male; Mice; Mice, Inbred BALB C; Organ Size; Vascular Endothelial Growth Factor A | 2008 |
Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
Topics: Age of Onset; Aged; Aged, 80 and over; Albuminuria; Arginine; Blood Glucose; Bone Density; Creatinine; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lysine; Male; Middle Aged; Postmenopause; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Risk Factors; Spinal Fractures | 2009 |
Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Predictive Value of Tests; Young Adult | 2010 |
Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
Topics: Albuminuria; Animals; Arginine; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glycated Hemoglobin; Glycation End Products, Advanced; Guanidines; Kinetics; Lysine; Male; Metabolic Clearance Rate; Rats; Rats, Inbred Lew; Reference Values; Skin | 1999 |
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Topics: Albuminuria; Arginine; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Reference Values | 1999 |